Recent advances in managing chronic HCV... | F1000Research
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant | ACS Omega
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C Online
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
Learning the ABC's of Today's Hepatitis C Medications
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Evolution of efficacious pangenotypic hepatitis C virus therapies - Ashraf - 2019 - Medicinal Research Reviews - Wiley Online Library
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Structure-activity relationships of fluorene compounds inhibiting HCV variants - ScienceDirect
Epclusa (sofosbuvir + velpatasvir)
Velpatasvir - an overview | ScienceDirect Topics
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Velpatasvir | C49H54N8O8 - PubChem
Sofosbuvir/velpatasvir: A promising combination
PathWhiz
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India | PLOS ONE
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
Sofosbuvir - Wikipedia
Advances in Treatment of Hepatitis C | IntechOpen
Epclusa, INN-sofosbuvir/velpatasvir
